- /
- Supported exchanges
- / US
- / NONOF.PINK
Novo Nordisk A/S (NONOF PINK) stock market data APIs
Novo Nordisk A/S Financial Data Overview
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Novo Nordisk A/S (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Novo Nordisk A/S data using free add-ons & libraries
Get Novo Nordisk A/S Fundamental Data
Novo Nordisk A/S Fundamental data includes:
- Net Revenue: 309 064 M
- EBITDA: 153 295 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-06
- EPS/Forecast: 5.46
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novo Nordisk A/S News
New
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the Rules
DIA 2026 Global Annual Meeting brings together regulators from four continents, 20 of the world's leading pharmaceutical companies, and more than 4,100 drug development professionals — June 14–18 ...
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index increasing 0.1% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
LLY Stock Pops 16% After Beat-and-Raise Q1: Buy, Hold or Take Profits?
Eli Lilly and Company’s LLY stock has risen 16.2% since it announced robust first-quarter 2026 results on April 30. The company crushed estimates for both earnings and sales. Earnings rose 156% yea...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.